1. Home
  2. SION vs DPG Comparison

SION vs DPG Comparison

Compare SION & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • DPG
  • Stock Information
  • Founded
  • SION 2019
  • DPG 2011
  • Country
  • SION United States
  • DPG United States
  • Employees
  • SION N/A
  • DPG N/A
  • Industry
  • SION
  • DPG Trusts Except Educational Religious and Charitable
  • Sector
  • SION
  • DPG Finance
  • Exchange
  • SION NYSE
  • DPG Nasdaq
  • Market Cap
  • SION 564.4M
  • DPG 465.0M
  • IPO Year
  • SION 2025
  • DPG N/A
  • Fundamental
  • Price
  • SION $13.69
  • DPG $12.28
  • Analyst Decision
  • SION Strong Buy
  • DPG
  • Analyst Count
  • SION 1
  • DPG 0
  • Target Price
  • SION $32.00
  • DPG N/A
  • AVG Volume (30 Days)
  • SION 143.7K
  • DPG 150.1K
  • Earning Date
  • SION 05-12-2025
  • DPG 01-01-0001
  • Dividend Yield
  • SION N/A
  • DPG 9.09%
  • EPS Growth
  • SION N/A
  • DPG N/A
  • EPS
  • SION N/A
  • DPG N/A
  • Revenue
  • SION N/A
  • DPG N/A
  • Revenue This Year
  • SION N/A
  • DPG N/A
  • Revenue Next Year
  • SION N/A
  • DPG N/A
  • P/E Ratio
  • SION N/A
  • DPG N/A
  • Revenue Growth
  • SION N/A
  • DPG N/A
  • 52 Week Low
  • SION $7.26
  • DPG $7.90
  • 52 Week High
  • SION $25.19
  • DPG $13.58
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • DPG 53.00
  • Support Level
  • SION N/A
  • DPG $12.15
  • Resistance Level
  • SION N/A
  • DPG $12.45
  • Average True Range (ATR)
  • SION 0.00
  • DPG 0.21
  • MACD
  • SION 0.00
  • DPG -0.02
  • Stochastic Oscillator
  • SION 0.00
  • DPG 61.43

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About DPG Duff & Phelps Utility and Infrastructure Fund Inc.

Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting primarily from a high level of current income, with an emphasis on providing tax-advantaged dividend income.

Share on Social Networks: